Safety/Feasibility of Vonapanitase Following Angioplasty for Patients With Peripheral Artery Disease (PAD) Below the Knee (BTK)
Completed · Phase 1 · Has a placebo group
Conditions studied: Peripheral Artery Disease
In brief
The research study is designed to assess the technical feasibility and safety of a perivascular injection of vonapanitase delivered via micro-infusion catheter to the distal popliteal, tibial or peroneal arteries immediately following successful angioplasty.
Key facts
- Study ID
- NCT02956993
- Run by
- Proteon Therapeutics
- People needed
- 29
- Starts
- 2016-11-01
- Expected to finish
- 2019-04-30
- Last updated by the study team
- 2019-05-02
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
Where it is running
- VA Medical Center Long Beach — Long Beach, California, United States
- VA Eastern Colorado Healthcare System — Denver, Colorado, United States
- UF Health at the University of Florida — Gainesville, Florida, United States
- Boston Medical Center — Boston, Massachusetts, United States
- Steward St. Elizabeth's Medical — Boston, Massachusetts, United States
- Metro Health Hospital — Wyoming, Michigan, United States
- Cardiothoracic and Vascular Surgeons — Austin, Texas, United States
- University of Virginia Health System — Charlottesville, Virginia, United States
- Medical College of Wisconsin — Milwaukee, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.